N/A N=71 Side Branch FFR After Provisional Stenting
Coronary Artery Disease
Primary: Number of Participants With Side Branch Compromise — 7; 9 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=30 A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose
Chronic Obstructive Pulmonary Disease
Primary: Maximum Plasma Concentration (Cmax) - Budesonide — 709.3 pg/mL
Phase 1 N=40 A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia
Schizophrenia
Primary: Incidence of Adverse Events (AEs), Serious Adverse Events (SAEs), and Adverse Events (AEs ) Leading to Study Discontinuation — 4; 4; 2; 4 count of participants
Phase 3 N=1,503 Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects
Influenza
Primary: Geometric Mean HI Titers (GMTs) After Vaccination in All Subjects — 329.76; 334.98; 334.98; 401.21 titers
N/A N=1,366 Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts
Thoracoabdominal Aneurysm · Abdominal Aortic Aneurysm
Primary: Freedom From Aneurysm Rupture — 22 Participants
Phase 3 N=23 Use of Topical NSAID to Reduce Pain in Oral Lichen Planus and Oral Lichenoid Lesions.
Oral Lichen Planus · Oral Lichenoid Mucositis · Oral Lichenoid Reaction
Primary: Self-reported Pain Scores Using 100m Visual Analog Scale 0-100 Pain Score. — 6.4; 12.3 mm
Phase 1 N=80 University of Alabama at Birmingham (UAB) Adult CBD Program
Epilepsy · Seizures
Primary: Number of Participants With Severe Adverse Events (SAEs) (Increase in Seizure Frequency by More Than 100% Leading to Emergency Room Visit or Hospitalization). — 0…
Phase 3 N=328 Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Fatigue
Primary: The Number of Participants With a Response in Terms of a Clinically Meaningful Improvement in Patient-reported Fatigue at 8 Weeks. — 29; 27; 29 Participants — p=0.9601
Phase 2 N=199 Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
B-cell Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Diffuse Well-differentiated Lymphocytic Lymphoma
Primary: Number of Subjects With Adverse Events — 199 Participants
Phase 2 N=70 A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Solid Tumor
Primary: Phases 1 & 2: Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs — 9; 9; 11; 9 Participants
N/A N=22 Effect of a Novel Reamer-Irrigator-Aspirator on the Incidence of Fat Embolism
Embolism · Femoral Fractures
Primary: Measurement of Embolic Debris — 5.3; 4.05 score on a scale
N/A N=40 Effect of Warm Saline Irrigation on Bleeding in Mandibular Third Molar Surgery
Surgical Blood Loss · Third Molar
Primary: Amount of Bleeding in Cubic Centimetre — 11.95; 8.75 Cubic Centimeter
Phase 4 N=211 Glargine U300 Hospital Trial
Type 2 Diabetes
Primary: Mean Daily Blood Glucose Concentration Inpatient — 186; 184 mg/dL
N/A N=141 Study Comparing Appearance and Function of Three Different Dental Implant Designs When Placed in Front Region of Upper Jaw
Jaw, Edentulous, Partially
Primary: Buccal Soft Tissue (Gum) Changes, Measured as Mid-buccal Gingival Zenith (GZ) Scores. — 0.08; -0.10; 0.00 Millimeter
Phase 1 N=14 A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants
Healthy Volunteers
Primary: Maximum Concentration (Cmax) of RO7017773 in Plasma — 458; 516 ng/mL